Clinical Trial Infographics

Eicosanoids are lipid-based mediators which play crucial roles in the inflammatory response and the development of ASCVD. This infographic delves into the intricate involvement of eicosanoids in atherosclerosis and highlights how icosapent ethyl serves as a key therapeutic option to mitigate ASCVD risks.

First published: February 11, 2025  

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in cholesterol homeostasis and inflammation, platelet activation, and atherosclerosis disease progression.
This infographic presents the physiological functions and molecular features that make PCSK9 an attractive therapeutic target for cardiovascular diseases.
Various strategies for targeting PCSK9 and clinical trials involving PCSK9-inhibitors are also delineated.

First published: March 21, 2024  

In this infographic, we look at current treatment strategies and future innovations.

First published: November 8, 2023